Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 2008 | 2018 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.905 | 42 | 3 | 1993 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1999 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 2 | 2005 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2006 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2006 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1996 | 2019 | ||||||||
|
adhesion G protein-coupled receptor E2 | 0.581 | 0.615 | 2.8E-28 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1997 | 2019 | ||||||||
|
adhesion G protein-coupled receptor E5 | 0.601 | 0.538 | 3.1E-06 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1997 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2002 | 2020 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1993 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2000 | 2019 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2013 | 2018 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1988 | 2019 | ||||||||
|
Kruppel like factor 4 | 0.449 | 0.769 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2012 | 2019 | ||||||||
|
SRY-box transcription factor 9 | 0.419 | 0.846 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 1999 | 2018 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1994 | 2015 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2013 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2018 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 |